In 2015 a study found vitamin C can kill tumour cells that carry a common cancer-causing mutation – in mice. In fact, many studies are investigating the therapeutic potential of Vitamin C, especially as a potential cancer treatment. This article explains various study outcomes and how intravenous dosing is seemingly most effective.
High dose vitamin C therapies are increasingly reporting positive results in cases previously deemed as ‘no hope’, especially with some cancer cases. This article, written by a practicing vet, conveys results from his trials in high dose vitC in dogs with cancer, as well as other life-threatening illnesses showing its benefits and continuing promise.
Holistic vet, Dr Rose DeLeva, writes that she has used intravenous Vitamin C therapy for dogs with cancer for almost 20 years with fantastic results. Not remissions, but almost always improved quality of life and often valuable extended life spans beyond prognosis. She says Vitamin C is one of the most potent biological antioxidants on the planet.
Twelve year old American Staffy, Muttley, was diagnosed with terminal cancer and after chemo and 5 surgeries the vets told his humans there was nothing else they could do. In a last ditch effort his humans tried low-dose cannabis oil and were amazed and thrilled by the results.
A Harvard-trained, integrative oncologist shares his excitement for curcumin as an anti-cancer agent and the overall research to support his interest. He explains the targets and pathways curcumin activates and provides a summary of current research.
Through x-ray crystallography researchers see curcumin bind to a specific kinase enzyme at the atomic level. This leads to its inhibition which “impairs cell proliferation and reduces cancer burden”. But curcumin alone may not be sufficient…
The good folks at The Truth About Cancer explain the exciting research into curcumin in cancer treatments as well as other health issues. There is more research to do but curcumin is showing real promise in helping to alleviate cancer, pain and inflammation.
Recent research has looked into mushrooms and their extracts and whether they can prevent or stop cancer, reduce treatment side effects, or increase life spans.
Paul Stamets is the world’s leading mind on mushrooms, their medicinal value and our evolutionary interdependence. This talk is an extract from one of his many mind-blowing presentations of his research.
Research indicates mushrooms have possible anti-cancer, antiviral, anti-inflammatory and liver protective activities. These six mushrooms are some of the most well-researched, rich in polysaccharides and beta glucans, the primary immune-enhancing constituents.
Myrrh was mentioned more frequently than any other plant in Hippocrates’ medical writings and of course its known for being a gift of the Kings. The Truth About Cancer gives their view on Myrrh here.
Cannabidiol (CBD) is a non-psychoactive compound of the cannabis plant that interacts with, or rebalances, our Endocannabinoid system which, among other functions, regulates the immune system response of mammals (such as humans and dogs). There is an ever increasing body of research showing that CBD has a positive effect on the side effects of chemotherapy…
Studies have shown that deficiency in Vitamin D may be connected to prevalence of cancer in both humans and dogs. In 2008, the Journal of Cell Biology published research that found “vitamin D can adjust almost everything in the cancer cell, from its genetic messaging to its cytoskeleton. It can switch genes on and off,…
Known as The Miracle Tree, or more formally as Moringa Olefeira, moringa has been recognized by America’s very conservative National Institute of Health and the cancer establishment of Memorial Sloan-Kettering Institute as being effective in reducing tumour size and proliferation. It has also been endorsed by the World Health Organisation for its nutritional density. It…
Turkey tail is the humble fungus at the centre of a $5.4M collaboration between Bastyr University, the University of Washington and others, funded by the NIH.